WANG, Y., X. ZHOU, K. OBEROI, R. PHELPS, R. COUWENHOVEN, M. SUN, A. REZZA, G. HOLMES, Ch.J. PERCIVAL, J. FRIEDENTHAL, Pavel KREJČÍ, J.T. RICHTSMEIER, D.L. HUSO, Michael RENDL and E. WANG JABS. p38 Inhibition ameliorates skin and skull abnormalities in Fgfr2 Beare-Stevenson mice. The journal of clinical investigation. [New York, N.Y.]: American Society for Clinical Investigation, 2012, vol. 122, No 6, p. 2153-2164. ISSN 0021-9738. Available from: https://dx.doi.org/10.1172/JCI62644.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name p38 Inhibition ameliorates skin and skull abnormalities in Fgfr2 Beare-Stevenson mice.
Authors WANG, Y. (840 United States of America), X. ZHOU (840 United States of America), K. OBEROI (840 United States of America), R. PHELPS (840 United States of America), R. COUWENHOVEN (840 United States of America), M. SUN (840 United States of America), A. REZZA (840 United States of America), G. HOLMES (840 United States of America), Ch.J. PERCIVAL (840 United States of America), J. FRIEDENTHAL (840 United States of America), Pavel KREJČÍ (203 Czech Republic, guarantor, belonging to the institution), J.T. RICHTSMEIER (840 United States of America), D.L. HUSO (840 United States of America), Michael RENDL (840 United States of America) and E. WANG JABS (840 United States of America).
Edition The journal of clinical investigation, [New York, N.Y.], American Society for Clinical Investigation, 2012, 0021-9738.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30105 Physiology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 12.812
RIV identification code RIV/00216224:14310/12:00065919
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1172/JCI62644
UT WoS 000304736300023
Keywords in English p38; skin; skull; FGFR2; Beare-Stevenson syndrome
Tags AKR, rivok, ZR
Changed by Changed by: Ing. Zdeňka Rašková, učo 140529. Changed: 25/4/2014 14:05.
Abstract
Beare-Stevenson cutis gyrata syndrome (BSS) is a human genetic disorder characterized by skin and skull abnormalities. BSS is caused by mutations in the FGF receptor 2 (FGFR2), but the molecular mechanisms that induce skin and skull abnormalities are unclear. We developed a mouse model of BSS harboring a FGFR2 Y394C mutation and identified p38 MAPK as an important signaling pathway mediating these abnormalities. Fgfr2+/Y394C mice exhibited epidermal hyperplasia and premature closure of cranial sutures (craniosynostosis) due to abnormal cell proliferation and differentiation. We found ligand-independent phosphorylation of FGFR2 and activation of p38 signaling in mutant skin and calvarial tissues. Treating Fgfr2+/Y394C mice with a p38 kinase inhibitor attenuated skin abnormalities by reversing cell proliferation and differentiation to near normal levels. This study reveals the pleiotropic effects of the FGFR2 Y394C mutation evidenced by cutis gyrata, acanthosis nigricans, and craniosynostosis and provides a useful model for investigating the molecular mechanisms of skin and skull development. The demonstration of a pathogenic role for p38 activation may lead to the development of therapeutic strategies for BSS and related conditions, such as acanthosis nigricans or craniosynostosis.
Links
GAP305/11/0752, research and development projectName: Molekulární základy FGFR3 signalingu v kostní dysplázii
Investor: Czech Science Foundation
GA301/09/0587, research and development projectName: Nové dráhy FGFR3 signalingu v achondroplázii
Investor: Czech Science Foundation, Novel pathway of FGFR3 signaling in achondroplasia
MSM0021622430, plan (intention)Name: Funkční a molekulární charakteristiky nádorových a normálních kmenových buněk - identifikace cílů pro nová terapeutika a terapeutické strategie
Investor: Ministry of Education, Youth and Sports of the CR, Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies
PrintDisplayed: 25/4/2024 04:14